Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia
- PMID: 33125433
- PMCID: PMC7598518
- DOI: 10.1371/journal.pone.0241258
Silent disease and loss of taste and smell are common manifestations of SARS-COV-2 infection in a quarantine facility: Saudi Arabia
Abstract
Objectives: In this study, we aimed to study the clinical presentations, and viral clearance of SARS-COV-2 positive quarantined individuals.
Design: Cross-sectional study.
Setting: Governmental- designated facility in the eastern province, Saudi Arabia.
Participants: 128 laboratory-confirmed COVID-19 quarantined individuals who had a history of travel abroad in the last 14 days before the quarantine or were in direct contact with laboratory-confirmed cases. The study was from March 18th-till April 16th.
Primary and secondary measures: The clinical presentation, prevalence of asymptomatic carriers among SARS-COV-2 positive quarantined subjects, and the difference between virus clearance among symptomatic and asymptomatic individuals.
Results: Sixty-nine of the 128 residents (54%) were completely asymptomatic until the end of the study. The remaining 59 residents (46%) had only mild symptoms. The most common symptom was a sudden loss of smell and taste, accounting for 47.5%. The median time to virus clearance was significantly different between the two groups. Symptomatic residents cleared the virus at a median of 17 days (95% CI, 12.4-21.6) from the first positive PCR vs. 11days (95% CI, 8.7-13.3) in the asymptomatic group (P = 0.011). False-negative test results occurred in 18.8% of the total residents and false-positive results in 3%.
Conclusion: The prevalence of asymptomatic carriers among quarantined travelers and those identified by contact tracing is high in our study. Therefore, testing, tracing, and isolating travelers and contacts of laboratory-confirmed cases, regardless of symptoms, were very effective measures for early disease identification and containment. Loss of taste and smell were the most common presentations in our mild symptomatic residents and should be used as a screening tool for COVID-19. The persistent positive PCR beyond 14 days observed in the mild symptomatic residents despite being symptoms free, warrant further studies to determine its implications on disease spread and control.
Conflict of interest statement
no competing interest exist.
Similar articles
-
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.Lancet Infect Dis. 2021 Mar;21(3):333-343. doi: 10.1016/S1473-3099(20)30833-1. Epub 2020 Nov 2. Lancet Infect Dis. 2021. PMID: 33152271 Free PMC article.
-
New onset of loss of smell or taste in household contacts of home-isolated SARS-CoV-2-positive subjects.Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2637-2640. doi: 10.1007/s00405-020-06066-9. Epub 2020 May 24. Eur Arch Otorhinolaryngol. 2020. PMID: 32449021 Free PMC article.
-
Prevalence of Chemosensitive Neurological Disorders of Smell and Taste and Association with Blood Groups in SARS-CoV-2 Patients: Cross-Sectional Study.Viruses. 2023 May 30;15(6):1277. doi: 10.3390/v15061277. Viruses. 2023. PMID: 37376577 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Travel-related control measures to contain the COVID-19 pandemic: a rapid review.Cochrane Database Syst Rev. 2020 Oct 5;10:CD013717. doi: 10.1002/14651858.CD013717. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Mar 25;3:CD013717. doi: 10.1002/14651858.CD013717.pub2. PMID: 33502002 Updated.
Cited by
-
Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay.Front Microbiol. 2021 Dec 3;12:770727. doi: 10.3389/fmicb.2021.770727. eCollection 2021. Front Microbiol. 2021. PMID: 34925278 Free PMC article.
-
Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis.F1000Res. 2021 Jan 21;10:40. doi: 10.12688/f1000research.28393.1. eCollection 2021. F1000Res. 2021. PMID: 33824716 Free PMC article.
-
The Prevalence and Pathophysiology of Chemical Sense Disorder Caused by the Novel Coronavirus.Front Public Health. 2022 Jun 6;10:839182. doi: 10.3389/fpubh.2022.839182. eCollection 2022. Front Public Health. 2022. PMID: 35734755 Free PMC article. Review.
-
Screening for Olfactory Dysfunction in COVID-19 Patients Using Quick Smell Identification Test.Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3002-3008. doi: 10.1007/s12070-021-02709-3. Epub 2021 Jun 30. Indian J Otolaryngol Head Neck Surg. 2022. PMID: 34226867 Free PMC article.
-
Mortality and survival in nonagenarians during the COVID-19 pandemic: Unstable equilibrium of aging.Front Med (Lausanne). 2023 Mar 2;10:1132476. doi: 10.3389/fmed.2023.1132476. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36936206 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous